| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print October 10, 2002
Am J Physiol Regu Physiol, 10.1152/ajpregu.00439.2002
Submitted on July 22, 2002
Accepted on September 20, 2002
1 Psychology, University of Washington, Seattle, WA, USA
2 Geriatric Research, Education and Clinical Center (GRECC), Veterans Affairs, Seattle, WA, USA
3 Research Service, Veterans Affairs, Seattle, WA, USA
4 Research Service, Veterans Affairs, Seattle, WA, USA; Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA
5 Psychology, University of Washington, Seattle, WA, USA; Research Service, Veterans Affairs, Seattle, WA, USA
* To whom correspondence should be addressed. E-mail: ngevans{at}u.washington.edu.
The anatomical connections of the paraventricular nucleus of the hypothalamus (PVN) are such that it is ideally situated to modulate and/or control autonomic responses to a variety of stressors, including hypoglycemia. In our experimental model of HAAF (hypoglycemia-associated autonomic failure), a syndrome in which the counterregulatory response to hypoglycemia is partially compromised via unknown mechanisms, activation of the PVN is blunted (15). We hypothesized that this blunted PVN activation during HAAF may be sufficient to cause the impaired counterregulatory response. To test this hypothesis, we anesthetized the PVN with lidocaine during insulin-induced hypoglycemia in rats and measured counterregulatory hormone levels. PVN inactivation decreased indices of the sympathoadrenal response (plasma epinephrine and norepinephrine) and the hypothalamic/pituitary axis response (ACTH). Inactivation decreased the peak epinephrine response to hypoglycemia by almost half (-42±6% from control; p=0.04) and the peak norepinephrine response by 34±5% (p=0.01). The peak plasma ACTH levels attained were suppressed by 35±6% (p=0.02). Adrenal corticosterone and pancreatic glucagon responses were not impaired. This pattern of neuroendocrine response is unlike that previously seen with our HAAF model. Control infusions of lidocaine one millimeter or more anterior or posterior to the PVN did not simulate this neuroendocrine pattern. Thus, it appears that decreased PVN activation, as occurs with HAAF, may be involved in specific components of HAAF (i.e., blunting the sympathoadrenal and HPA response), but not in others (i.e. blunting the glucagon response).
This article has been cited by other articles:
|
|
 |
|
  S. Al-Noori, N. M. Sanders, G. J. Taborsky Jr., C. W. Wilkinson, A. Zavosh, C. West, C. M. Sanders, and D. P. Figlewicz Recurrent hypoglycemia alters hypothalamic expression of the regulatory proteins FosB and synaptophysin Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1446 - R1454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. McCrimmon, M. Shaw, X. Fan, H. Cheng, Y. Ding, M. C. Vella, L. Zhou, E. C. McNay, and R. S. Sherwin Key Role for AMP-Activated Protein Kinase in the Ventromedial Hypothalamus in Regulating Counterregulatory Hormone Responses to Acute Hypoglycemia Diabetes, February 1, 2008; 57(2): 444 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Sandoval, B. Gong, and S. N. Davis Antecedent short-term central nervous system administration of estrogen and progesterone alters counterregulatory responses to hypoglycemia in conscious male rats Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1511 - E1516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Cheng, L. Zhou, W. Zhu, A. Wang, C. Tang, O. Chan, R. S. Sherwin, and R. J. McCrimmon Type 1 corticotropin-releasing factor receptors in the ventromedial hypothalamus promote hypoglycemia-induced hormonal counterregulation Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E705 - E712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Sanders, G. J. Taborsky Jr., C. W. Wilkinson, W. Daumen, and D. P. Figlewicz Antecedent Hindbrain Glucoprivation Does Not Impair the Counterregulatory Response to Hypoglycemia Diabetes, January 1, 2007; 56(1): 217 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Cryer Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes Diabetes, December 1, 2005; 54(12): 3592 - 3601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Richardson, P. Thomas, J. Ryder, and D. Kerr Influence of Caffeine on Frequency of Hypoglycemia Detected by Continuous Interstitial Glucose Monitoring System in Patients With Long-Standing Type 1 Diabetes Diabetes Care, June 1, 2005; 28(6): 1316 - 1320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. de Vries, M. A. Lawson, and J. Lee Beverly Dissociation of hypothalamic noradrenergic activity and sympathoadrenal responses to recurrent hypoglycemia Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2004; 286(5): R910 - R915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Evans, C. W. Wilkinson, P. Gronbeck, J. L. Bennett, A. Zavosh, G. J. Taborsky Jr, and D. P. Figlewicz Inactivation of the DMH selectively inhibits the ACTH and corticosterone responses to hypoglycemia Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2004; 286(1): R123 - R128. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
